AGP Executive Report
Last update: 8 hours agoCancer Watch: Taiwan reported cancer as the No. 1 cause of death for the 44th straight year in 2025, with 199,576 total deaths and cancer still leading (54,838 deaths), followed by heart disease and pneumonia. Sports Medicine: Doctors in Taipei warn that World Cup energy is boosting soccer participation, but injuries are common—especially thigh, ankle, and knee problems—so warm-ups, conditioning, and recovery matter. Clinical Research: Kelun-Biotech’s sacituzumab tirumotecan (sac-TMT) plus osimertinib results were published in Cancer Cell, supporting a first-line strategy for EGFR-mutant NSCLC. Biotech Dealmaking: Antengene announced an exclusive global license with K2 Therapeutics for ATG-106 (CDH6 x CD3 bispecific TCE), with major upfront and milestone payments. Public Health Tech: New Taipei City launched a hornet hotspot warning system using a Line Bot and mapping from NTU to help residents avoid sting-risk zones. Healthcare Supply Chain: Pharmicell is described as the sole supplier of a key low-dielectric material used in AI-server circuit boards, with demand tied to Nvidia-linked production. Wellness & Food: Taiwan’s mangoes entered the French market, while nutrition guidance for festival foods like zongzi continues to circulate.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
